R A Dlodlo1, Z E Hwalima2, S Sithole2, K C Takarinda3, K Tayler-Smith4, A D Harries5. 1. International Union Against Tuberculosis and Lung Disease, Bulawayo, Zimbabwe. 2. Health Services Department, City of Bulawayo, Bulawayo, Zimbabwe. 3. International Union Against Tuberculosis and Lung Disease, Bulawayo, Zimbabwe ; AIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe. 4. Médecins Sans Frontières, Operational Centre Brussels, Operational Research Unit, MSF-Luxembourg, Luxembourg. 5. International Union Against Tuberculosis and Lung Disease, Bulawayo, Zimbabwe ; London School of Hygiene & Tropical Medicine, London, UK.
Abstract
SETTING: Emakhandeni Clinic provides decentralised and integrated tuberculosis (TB) and human immunodeficiency virus (HIV) care in Bulawayo, Zimbabwe. OBJECTIVES: To compare HIV care for presumptive TB patients with and without TB registered in 2013. DESIGN: Retrospective cohort study using routine programme data. RESULTS: Of 422 registered presumptive TB patients, 26% were already known to be HIV-positive. Among the remaining 315 patients, 255 (81%) were tested for HIV, of whom 190 (75%) tested HIV-positive. Of these, 26% were diagnosed with TB and 71% without TB (3% had no TB result recorded). For the 134 patients without TB, antiretroviral treatment (ART) eligibility data were recorded for 42 (31%); 95% of these were ART eligible. Initiation of cotrimoxazole preventive therapy (CPT) and ART was recorded for respectively 88% and 90% of HIV-positive patients with TB compared with respectively 40% and 38% of HIV-positive patients without TB (P < 0.001). CONCLUSION: Presumptive TB patients without TB had a high HIV positivity rate and, for those with available data, most were ART eligible. Unlike HIV-positive patients diagnosed with TB, CPT and ART uptake for these patients was poor. A 'test and treat' approach and better service linkages could be life-saving for these patients, especially in southern Africa, where there are high burdens of HIV and TB.
SETTING: Emakhandeni Clinic provides decentralised and integrated tuberculosis (TB) and human immunodeficiency virus (HIV) care in Bulawayo, Zimbabwe. OBJECTIVES: To compare HIV care for presumptive TB patients with and without TB registered in 2013. DESIGN: Retrospective cohort study using routine programme data. RESULTS: Of 422 registered presumptive TB patients, 26% were already known to be HIV-positive. Among the remaining 315 patients, 255 (81%) were tested for HIV, of whom 190 (75%) tested HIV-positive. Of these, 26% were diagnosed with TB and 71% without TB (3% had no TB result recorded). For the 134 patients without TB, antiretroviral treatment (ART) eligibility data were recorded for 42 (31%); 95% of these were ART eligible. Initiation of cotrimoxazole preventive therapy (CPT) and ART was recorded for respectively 88% and 90% of HIV-positive patients with TB compared with respectively 40% and 38% of HIV-positive patients without TB (P < 0.001). CONCLUSION: Presumptive TB patients without TB had a high HIV positivity rate and, for those with available data, most were ART eligible. Unlike HIV-positive patients diagnosed with TB, CPT and ART uptake for these patients was poor. A 'test and treat' approach and better service linkages could be life-saving for these patients, especially in southern Africa, where there are high burdens of HIV and TB.
Entities:
Keywords:
SORT IT; antiretroviral treatment; operational research; sub-Saharan Africa
Authors: Shungu S Munyati; Temba Dhoba; Evelyn D Makanza; Stanley Mungofa; Maureen Wellington; Junior Mutsvangwa; Lovemore Gwanzura; James Hakim; Morgan Nyakabau; Peter R Mason; Valerie Robertson; Simba Rusakaniko; Anthony E Butterworth; Elizabeth L Corbett Journal: Clin Infect Dis Date: 2005-05-12 Impact factor: 9.079
Authors: P Srikantiah; R Lin; M Walusimbi; A Okwera; H Luzze; C C Whalen; W H Boom; D V Havlir; E D Charlebois Journal: Int J Tuberc Lung Dis Date: 2007-02 Impact factor: 2.373
Authors: A Porskrog; M Bjerregaard-Andersen; I Oliveira; L C Joaquím; C Camara; P L Andersen; P Rabna; P Aaby; C Wejse Journal: Int J Tuberc Lung Dis Date: 2011-04 Impact factor: 2.373
Authors: Munyaradzi Dimairo; Peter MacPherson; Tsitsi Bandason; Abbas Zezai; Shungu S Munyati; Anthony E Butterworth; Stanley Mungofa; Simba Rusikaniko; Katherine Fielding; Peter R Mason; Elizabeth L Corbett Journal: PLoS One Date: 2010-07-28 Impact factor: 3.240
Authors: J Odhiambo; W Kizito; A Njoroge; N Wambua; L Nganga; M Mburu; J Mansoer; L Marum; E Phillips; J Chakaya; K M De Cock Journal: Int J Tuberc Lung Dis Date: 2008-03 Impact factor: 2.373
Authors: P Macpherson; M Dimairo; T Bandason; A Zezai; S S Munyati; A E Butterworth; S Mungofa; S Rusakaniko; K Fielding; P R Mason; E L Corbett Journal: Int J Tuberc Lung Dis Date: 2011-10 Impact factor: 2.373
Authors: R T Ncube; K C Takarinda; C Zishiri; W van den Boogaard; N Mlilo; C Chiteve; N Siziba; F Trinchán; C Sandy Journal: Public Health Action Date: 2017-09-21
Authors: Khine Wut Yee Kyaw; Nang Thu Thu Kyaw; Myo Su Kyi; Sandar Aye; Anthony D Harries; Ajay M V Kumar; Nay Lynn Oo; Srinath Satyanarayana; Si Thu Aung Journal: PLoS One Date: 2020-06-18 Impact factor: 3.240
Authors: Marriott Nliwasa; Peter MacPherson; Ankur Gupta-Wright; Mphatso Mwapasa; Katherine Horton; Jon Ø Odland; Clare Flach; Elizabeth L Corbett Journal: J Int AIDS Soc Date: 2018-07 Impact factor: 5.396
Authors: Ajay Mv Kumar; Devesh Gupta; Ashok Kumar; R S Gupta; Avinash Kanchar; Raghuram Rao; Suresh Shastri; M D Suryakanth; Chethana Rangaraju; Balaji Naik; Deepak K Guddemane; Prashant Bhat; Achuthan Sreenivas Nair; Anthony David Harries; Puneet Dewan Journal: PLoS One Date: 2016-05-31 Impact factor: 3.240